WallStreetZenWallStreetZen

NASDAQ: ABIO
Arca Biopharma Inc Stock Ownership - Who owns Arca Biopharma?

Insider buying vs selling

Have Arca Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Funicular Funds LP10% Owner2022-12-161,420,000$2.50
$3.55MBuy

1 of 1

ABIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABIO insiders and whales buy or sell their stock.

ABIO Shareholders

What type of owners hold Arca Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell70.93%10,221,465$21.57MInsider
Krishna Kittu Kolluri70.93%10,221,465$21.57MInsider
Joshua Makower70.93%10,221,465$21.57MInsider
David M. Mott70.93%10,221,465$21.57MInsider
Anthony A. Florence Jr.70.93%10,221,465$21.57MInsider
Jon Sakoda70.93%10,221,465$21.57MInsider
Forest Baskett70.93%10,221,465$21.57MInsider
Peter J. Barris70.93%10,221,465$21.57MInsider
Peter W. Sonsini70.93%10,221,465$21.57MInsider
Ravi Viswanathan70.93%10,221,465$21.57MInsider

1 of 3

ABIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABIO1.74%98.26%Net Buying
IMMX2.53%31.87%Net Buying
ANGN14.85%24.83%Net Selling
HARP37.57%62.43%Net BuyingNet Buying
PCSA3.30%13.33%Net BuyingNet Buying

Arca Biopharma Stock Ownership FAQ

Who owns Arca Biopharma?

Arca Biopharma (NASDAQ: ABIO) is owned by 17.50% institutional shareholders, 989.61% Arca Biopharma insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Arca Biopharma shareholder, owning 10.22M shares representing 70.93% of the company. Scott D. Sandell's Arca Biopharma shares are currently valued at $21.57M.

If you're new to stock investing, here's how to buy Arca Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.